Publication | Open Access

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine

Nucleic Acid ChemistryMedicineOligonucleotidePharmacodynamic EvaluationPharmacotherapyDna Methyltransferase InhibitorPharmacologyBiomolecular Engineering